Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 81.41B | 77.06B | 70.85B | 66.39B | 62.12B |
Gross Profit | 9.89B | 9.53B | 8.66B | 8.52B | 7.74B |
EBITDA | 3.10B | 2.92B | 3.11B | 2.82B | 2.45B |
Net Income | 2.02B | 1.84B | 2.05B | 1.83B | 1.54B |
Balance Sheet | |||||
Total Assets | 46.62B | 47.73B | 43.88B | 41.56B | 40.19B |
Cash, Cash Equivalents and Short-Term Investments | 16.21B | 18.16B | 16.77B | 15.57B | 17.12B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 22.55B | 24.34B | 21.10B | 19.84B | 19.05B |
Stockholders Equity | 24.07B | 23.39B | 22.78B | 21.72B | 21.14B |
Cash Flow | |||||
Free Cash Flow | 1.59B | 2.54B | -525.17M | -136.90M | 673.91M |
Operating Cash Flow | 2.06B | 3.04B | 445.15M | 2.62B | 1.85B |
Investing Cash Flow | -2.17B | -219.47M | 1.92B | -2.89B | -1.28B |
Financing Cash Flow | -1.83B | -1.45B | -1.16B | -1.28B | -947.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.36B | 8.42 | 3.94% | 3.49% | -4.39% | ||
76 Outperform | ¥7.93B | 12.61 | 1.96% | 4.76% | 9.55% | ||
75 Outperform | ¥17.52B | 6.07 | 2.05% | 3.70% | 37.00% | ||
73 Outperform | ¥55.97B | 8.82 | 3.62% | 2.22% | 21.19% | ||
71 Outperform | ¥14.49B | 12.02 | 2.50% | 5.93% | -36.11% | ||
70 Outperform | ¥38.70B | 18.36 | 3.86% | 5.81% | 8.10% | ||
51 Neutral | $7.83B | -0.15 | -40.10% | 2.29% | 21.46% | -2.01% |